Hernia Mesh Recalls
Recalled hernia mesh products include the Atrium Medical C-QUR Mesh, Bard Composix Kugel hernia patch and Ethicon Proceed Surgical Mesh. From 2005 through 2021, hernia mesh manufacturers recalled more than 211,000 units of hernia mesh.
Board-certified physicians medically review Drugwatch.com content to ensure its accuracy and quality.
Drugwatch.com partners with Physicians’ Review Network Inc. to enlist specialists. PRN is a nationally recognized leader in providing independent medical reviews.
Reviewer specialties include internal medicine, gastroenterology, oncology, orthopedic surgery and psychiatry.
Drugwatch.com has been empowering patients for more than a decade
Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations.
Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.
The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.
About Drugwatch.com
- Assisting patients and their families since 2008.
- Helped more than 12,000 people find legal help.
- A+ rating from the Better Business Bureau.
- 5-star reviewed medical and legal information site.
Testimonials
"Drugwatch opened my eyes to the realities of big pharmacy. Having a family member with major depression and anxiety, I was looking for information on her medications. I found information that was very helpful, that her psychiatrist never told her."
Latest Hernia Mesh Recall Updates
No significant hernia mesh recalls have occurred since 2021. The Food and Drug Administration classified most from 2005 through 2021 as Class 2 recalls, indicating temporary or medically reversible side effects. C.R. Bard’s Kugel patch was a Class 1 recall, indicating serious health risks and possible death.
Three companies — Johnson & Johnson’s Ethicon, Bard Davol, and Atrium — were responsible for the most recalls.
As of December 2024, these three manufacturers, along with Covidien, faced a total of 26,246 hernia mesh lawsuits in four separate multidistrict litigations in federal court.
Which Hernia Mesh Products Have Been Recalled?
The FDA has different definitions for recalls and market withdrawals. With recalls, companies remove the product from the market voluntarily because they discovered a problem that could to legal action. The FDA rarely forces a manufacturer to recall a product.
Conversely, market withdrawals happen when the violation is not subject to legal action. Companies can take the product off the market or fix its violation to avoid a recall.
Some device recalls were due to packaging errors, while others faced market withdrawal due to high failure rates.
Severe complications included adhesions, bowel fistulas, punctured organs, device migration and bowel obstruction.
- Atrium Medical C-QUR Mesh
- In 2013, Atrium recalled over 145,000 units of C-QUR hernia mesh due to high humidity causing the mesh to stick to the package liner. The FDA classified this recall as a Class 2.
- Gentrix Surgical Matrix
- In February 2019, ACell recalled two Gentrix Surgical Matrix Thick products due to their failure to meet the company's tensile strength specifications. These meshes, made from biological materials, were designed to dissolve over time.
- Ethicon Physiomesh Flexible Composite Mesh (Market Withdrawal, Not Recall)
- Due to a high recurrence and reoperation rate, Ethicon recalled its Physiomesh Flexible Composite Mesh for laparoscopic use in Australia and Europe. In the U.S., however, it issued a 2016 market withdrawal instead of a recall.
- Ethicon Proceed Surgical Mesh
- Ethicon recalled over 18,000 units of its Proceed Surgical Mesh from 2005 to 2014. The FDA classified the recall as Class 2 due to problems such as packaging that could cause "delamination" and increase the risk of complications.
- Parietex Composite Parastomal Mesh
- In 2018, Covidien recalled 7,333 units of its Parietex Composite Parastomal Mesh due to mesh failure issues following parastomal hernia repair using the modified Sugarbaker repair technique. If your hernia mesh has been recalled, but you are not experiencing problems, you do not need to take action. If your mesh is on the recall list and you are experiencing complications, speak to your doctor immediately.
FDA Warnings, Reviews and Enforcement Actions
The FDA continually monitors hernia mesh for safety. It reviews adverse event reports from doctors, patients, manufacturers and others to identify problems with these medical devices. As of the latest update in July 2023, the agency has identified 55,000 adverse event reports related to hernia mesh.
“Many complications related to hernia repair with surgical mesh that have been reported to the FDA have been associated with recalled mesh products that are no longer on the market. Pain, infection, recurrence, adhesion, obstruction and perforation are the most common complications associated with recalled mesh.”
According to the University of California San Francisco Medical Center, “Many complications related to hernia repair with surgical mesh that have been reported to the FDA have been associated with recalled mesh products that are no longer on the market. Pain, infection, recurrence, adhesion, obstruction and perforation are the most common complications associated with recalled mesh.”
The FDA can take enforcement action if a company fails to make changes after FDA inspections of manufacturing facilities. In 2015, for example, the FDA requested a court injunction against Atrium Medical due to repeated warnings about issues at its C-QUR factory. The injunction blocked C-QUR manufacturing and sales until Atrium fixed the problems.
-
2021
Covidien recalled 129 units of Parietex hydrophilic anatomical mesh used in inguinal hernia repair after packages were found to contain the wrong device.
-
2018
The FDA averaged more than 500 monthly adverse event reports for all types of surgical mesh. This included almost 300 reports for Physiomesh and 200 for C-QUR in the year's first three months.
-
2016
Ethicon issued a market withdrawal of Physiomesh Flexible Composite Mesh products.
-
2016
Two large European hernia registries reported higher than average failure rates for Physiomesh Flexible Composite Mesh.
-
2015
A federal court granted the FDA an injunction against Atrium, ordering it to stop distributing and manufacturing medical devices from its Hudson, New Hampshire, plant. The shutdown remained in effect until Atrium complied with certain Federal Food, Drug and Cosmetic Act provisions.
-
2012
The FDA issued a warning letter to Atrium Medical saying Atrium failed to address reported infections and that its sterilization process was inadequate.
-
2010
The FDA approved Ethicon’s Physiomesh Flexible Composite Mesh.
-
2006
The FDA approved Atrium’s first C-QUR mesh products.
Recalled Mesh Lawsuits and Settlements
Hernia mesh patients have sued manufacturers, alleging that the mesh was faulty and posed hidden risks. Thousands of hernia mesh lawsuits have been consolidated into separate, federal multidistrict litigations (MDLs), which allowed the courts to streamline the legal process.
- Ethicon faced 16 Physiomesh lawsuits in federal MDL 2782.
- Atrium faced 564 C-QUR mesh lawsuits in MDL 2753.
- Bard faced 24,100 lawsuits for several of its polypropylene hernia mesh brands in MDL 2846.
- Covidien faced 1,566 lawsuits in MDL 3029.
Bard Davol originally faced more than 3,000 lawsuits in one of the earliest hernia mesh MDLs for its Kugel patch. After a trial loss, they settled 2,600 lawsuits for $184 million, and MDL 1842 closed in 2017.
Calling this number connects you with a Drugwatch.com representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch.com's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.
